Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Louis Dreyfus Holding is the parent company of the Louis Dreyfus Company (LDC), a global leader in the merchanting and processing of agricultural goods. While traditionally focused on commodities like grains, oilseeds, and coffee, the company has strategically expanded into the life sciences and healthcare sectors through its Food & Feed Solutions platform. LDC provides a range of pharmaceutical-grade ingredients, including glycerin and lecithin, and recently significantly expanded its footprint by acquiring BASF's Food and Health Performance Ingredients business. This acquisition adds specialized health ingredients such as plant sterols, omega-3 oils, and conjugated linoleic acid (CLA) to its portfolio, positioning the company as a key supplier to the global pharmaceutical, nutraceutical, and personal care industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Louis Dreyfus Holding.